Larvol Delta - Inhibition-of-Pim2-kinase-by-LT171861-promotes-DNA-damage-and-exhibits-enhanced-lethal-effects-with-PARP-Inhibitor-in-multiple-myeloma

LT-171-861 - China Pharmaceutical University

Lynparza (olaparib) - Merck (MSD), AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/34111425

Jun 11, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next